Barclays Private Equity (Barclays PE), the buyout arm of Barclays Bank, has acquired a majority stake in France’s Unither Pharmaceuticals, The Wall Street Journal reports. Financial terms of the deal involving the stake sale of the contract manufacturer of sterile, unit dose preparations were not disclosed.
Investment company ING Parcom Private Equity and the group’s shareholders CM-CIC Investissement and Picardie Investissement, are reinvesting in Unither. In 2010, Unither generated revenue of €151 million and its products include consumer-ready drugs and generic products such as eyewashes and anti-asthma drugs.
Click here for the story from The Wall Street Journal.